Increased expression of MIF has been reported in hepatocellular carcinoma, prostate carcinoma, lung adenocarcinoma, neuroblastoma and colorectal cancers [13,24,25,27,29]. This evidence concerns the gene MIF and hepatocellular carcinoma.